Rising fatality rate exposes gaps in Lassa fever response
Nigeria’s fight against Lassa fever is entering a troubling phase—one defined not by the number of infections, but by the growing number of deaths. New figures from the Nigeria Centre
Nigeria’s fight against Lassa fever is entering a troubling phase—one defined not by the number of infections, but by the growing number of deaths. New figures from the Nigeria Centre for Disease Control and Prevention (NCDC) reveal a stark and unsettling reality: even as weekly confirmed cases decline, more Nigerians are dying from the disease. In its Epidemiological Week 14 report for 2026, the agency noted that confirmed cases dropped slightly from 26 to 22. On the surface, this suggests progress. But beneath that modest improvement lies a far more alarming development. The case fatality rate has surged to 24.8 per cent, a significant jump from 18.8 per cent recorded during the same period in 2025. In effect, nearly one in four confirmed patients is now dying—a reversal that signals deepening cracks in disease management.
This paradox—fewer cases but higher deaths—points to a more complex crisis. It suggests that patients are not accessing care early enough, or are arriving at health facilities in critical condition when treatment options are already limited. It also raises questions about the reach and effectiveness of ongoing interventions, especially in communities where awareness remains low and healthcare access is constrained. So far this year, the country has recorded 170 deaths from Lassa fever, a figure that underscores the persistent challenges confronting Nigeria’s public health system. Despite years of experience managing outbreaks, the disease continues to expose weaknesses in early detection, treatment delivery, and health-seeking behaviour.
The burden of infection remains heavily concentrated in a handful of states. Bauchi leads with the highest proportion of confirmed cases, followed by Ondo, Taraba, Edo, and Benue. Together, these five states account for about 84 per cent of infections recorded in 2026, reflecting entrenched transmission patterns linked to environmental conditions, housing quality, and exposure to rodents—the primary carriers of the virus. Yet the disease is far from contained. A total of 22 states and 94 Local Government Areas have reported confirmed cases this year, including Plateau, Ebonyi, and Kogi. This wider geographic spread, even amid declining weekly figures, suggests that transmission remains active and that containment efforts are yet to fully take hold.
Advertisement
300x250
READ ALSO: CNG mishaps
Demographically, the outbreak is hitting young adults hardest. The most affected age group falls between 21 and 30 years, with a median age of 30. This places a disproportionate burden on Nigeria’s working-age population, with implications that extend beyond health to productivity and household stability. While both men and women are affected, the infection rate is slightly higher among males. Equally concerning is the continued infection of healthcare workers. The NCDC confirmed new cases among medical personnel during the reporting period, highlighting ongoing vulnerabilities in infection prevention and control practices within treatment centres. For frontline workers, the risk is not abstract; it is immediate and, in some cases, fatal. Each infection among health workers not only reduces available manpower but also heightens anxiety across the system.
In response, the NCDC has intensified its national strategy, working closely with international partners such as the World Health Organisation, UNICEF, Médecins Sans Frontières, and the Centers for Disease Control and Prevention in the United States. A multi-sectoral Incident Management System has been activated to coordinate surveillance, case management, and rapid response efforts across affected states. Teams have been deployed to high-burden areas, treatment centres are receiving essential supplies including Ribavirin and protective equipment, and community sensitisation campaigns are being scaled up. These measures are designed to interrupt transmission chains and improve patient outcomes. But the rising fatality rate suggests that these interventions, while necessary, are not yet sufficient.
At the heart of the crisis are familiar but stubborn challenges. Many patients still present late to health facilities, often after attempting self-medication or delaying care due to financial constraints. In some communities, awareness of Lassa fever symptoms remains low, leading to missed opportunities for early diagnosis. Poor sanitation and rodent infestation continue to fuel transmission, particularly in densely populated or underserved areas. These factors combine to create a dangerous cycle: infection occurs, recognition is delayed, treatment comes too late, and the risk of death increases. Breaking that cycle requires more than clinical response; it demands sustained community engagement, improved affordability of care, and stronger primary health systems.
Lassa fever, an acute viral haemorrhagic illness transmitted through contact with contaminated food or household items, is both preventable and treatable—especially when detected early. But time remains the most critical factor. The difference between survival and death often lies in how quickly a patient receives appropriate care. The NCDC has urged state governments to deepen public awareness and strengthen grassroots response mechanisms, while calling on healthcare workers to maintain vigilance and adhere strictly to infection control protocols. The message is clear: reducing infections is not enough if those infected continue to die at increasing rates.
